| 摘要 |
The invention relates to tablets with improved bioavailability of the active ingredient dichloromethylenediphosphonic acid or a physiologically tolerated salt thereof and with a content of microcrystalline cellulose as pharmaceutical ancillary substance, to drug packs containing these tablets, to the use of the active ingredient dichloromethylenediphosphonic acid together with microcrystalline cellulose for producing a tablet with improved bioavailability, and to the process for the production of the tablet.
|
